These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 8731716)

  • 1. Toxic epidermal necrolysis following chlorpromazine ingestion complicated by SIADH.
    Purcell P; Valmana A
    Postgrad Med J; 1996 Mar; 72(845):186. PubMed ID: 8731716
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparison of reporting of Stevens-Johnson syndrome and toxic epidermal necrolysis in association with selective COX-2 inhibitors.
    La Grenade L; Lee L; Weaver J; Bonnel R; Karwoski C; Governale L; Brinker A
    Drug Saf; 2005; 28(10):917-24. PubMed ID: 16180941
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Demonstration of basal cell immunofluorescence in drug-induced toxic epidermal necrolysis.
    Stein KM; Schlappner OL; Heaton CL; Decherd JW
    Br J Dermatol; 1972 Mar; 86(3):246-52. PubMed ID: 4553158
    [No Abstract]   [Full Text] [Related]  

  • 4. Syndrome of inappropriate secretion of antidiuretic hormone in association with chlorpromazine ingestion.
    Tildesley HD; Toth E; Crockford PM
    Can J Psychiatry; 1983 Oct; 28(6):487-8. PubMed ID: 6640486
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stevens-Johnson syndrome and toxic epidermal necrolysis at the University Hospital of the West Indies, Jamaica.
    East-Innis AD; Thompson DS
    West Indian Med J; 2013 Sep; 62(7):589-92. PubMed ID: 24831894
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stevens Johnson syndrome-Toxic Epidermal Necrolysis Overlap induced by sulfasalazine treatment: a case report.
    Zizi N; Elmrahi A; Dikhaye S; Fihmi N; Alami Z
    Tunis Med; 2015 Jul; 93(7):413-5. PubMed ID: 26757493
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Stevens-Johnson syndrome and toxic epidermal necrolysis; therapy policy in these life-threatening illnesses. Netherlands Work Group Toxic Epidermal Necrolysis].
    van der Meer JB
    Ned Tijdschr Geneeskd; 1996 Jul; 140(30):1538-43. PubMed ID: 8765761
    [No Abstract]   [Full Text] [Related]  

  • 8. [Stevens-Johnson syndrome and toxic epidermal necrolysis: retrospective study of 185 cases in Abidjan (Côte d'Ivoire)].
    Kourouma S; Sangaré A; Kaloga M; Kouassi I; Ecra E; Gbery I; Ahogo C; Kouassi A; Kassi K; Camara B
    Med Sante Trop; 2014; 24(1):94-8. PubMed ID: 24736218
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Medications as risk factors of Stevens-Johnson syndrome and toxic epidermal necrolysis in children: a pooled analysis.
    Levi N; Bastuji-Garin S; Mockenhaupt M; Roujeau JC; Flahault A; Kelly JP; Martin E; Kaufman DW; Maison P
    Pediatrics; 2009 Feb; 123(2):e297-304. PubMed ID: 19153164
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis Overlap Induced by Fexofenadine.
    Teo SL; Santosa A; Bigliardi PL
    J Investig Allergol Clin Immunol; 2017 Jun; 27(3):191-193. PubMed ID: 28570227
    [No Abstract]   [Full Text] [Related]  

  • 11. Toxic epidermal necrolysis and Stevens-Johnson syndrome: a review.
    Gerull R; Nelle M; Schaible T
    Crit Care Med; 2011 Jun; 39(6):1521-32. PubMed ID: 21358399
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Burn Center Care of Patients with Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis.
    Cartotto R
    Clin Plast Surg; 2017 Jul; 44(3):583-595. PubMed ID: 28576247
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Toxic Epidermal Necrolysis Related to Paliperidone Palmitate: First Case Report.
    Struye A; Depuydt C; Abdel Sater E; Dubois V
    J Clin Psychopharmacol; 2016 Jun; 36(3):279-82. PubMed ID: 26928057
    [No Abstract]   [Full Text] [Related]  

  • 14. Aetiology in sixteen cases of toxic epidermal necrolysis and Stevens-Johnson syndrome admitted within eight months in a teaching hospital.
    Yeung CK; Ma SY; Hon C; Peiris M; Chan HH
    Acta Derm Venereol; 2003; 83(3):179-82. PubMed ID: 12816151
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Causative Drugs of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in Israel.
    Maggio N; Firer M; Zaid H; Bederovsky Y; Aboukaoud M; Gandelman-Marton R; Noyman I; Ekstein D; Blatt I; Marom E; Schwartzberg E; Israel S; Ingber A; Brautbar C; Eyal S
    J Clin Pharmacol; 2017 Jul; 57(7):823-829. PubMed ID: 28181259
    [No Abstract]   [Full Text] [Related]  

  • 16. Case report: psychosis with Stevens-Johnson syndrome and toxic epidermal necrolysis.
    de Rego JA; Goldstein DM
    Hillside J Clin Psychiatry; 1985; 7(2):141-8. PubMed ID: 4077031
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fatal Stevens-Johnson syndrome/toxic epidermal necrolysis induced by allopurinol-rituximab-bendamustine therapy.
    Fallon MJ; Heck JN
    J Oncol Pharm Pract; 2015 Oct; 21(5):388-92. PubMed ID: 25005569
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effectiveness, safety and tolerability of cyclosporine versus supportive treatment in Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis: A record-based study.
    Mohanty S; Das A; Ghosh A; Sil A; Gharami RC; Bandyopadhyay D; Das NK
    Indian J Dermatol Venereol Leprol; 2017; 83(3):312-316. PubMed ID: 28366923
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Soluble Fas ligand: is it a critical mediator of toxic epidermal necrolysis and Stevens-Johnson syndrome?
    Murata J; Abe R
    J Invest Dermatol; 2007 Apr; 127(4):744-5. PubMed ID: 17363955
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Toxic epidermal necrolysis (syndrome Lyell) versus Stevens-Johnson syndrome].
    Jezierska-Krupa B; Hyla-Klekot L
    Pediatr Pol; 1996 Jul; 71(7):615-20. PubMed ID: 8803466
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.